Tag: corporation

PALM BEACH, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a growing demand for cryptocurrency payments applications. A report from Grand View Research projected that the global cryptocurrency payment apps market size was estimated at USD 556.9 million in 2024 and is projected to reach USD 2,404.1 million by 2033, growing at a CAGR of 17.8% from 2025 to 2033. The emergence of Web3 and blockchain technology created the need for cryptocurrency payment apps to enable individuals to conduct seamless transactions. The report said: “The growing adoption of cryptocurrencies globally is the key driver for the market's expansion. People are encouraged to use cryptocurrency payment platforms owing to the decentralized nature of the blockchain, which eliminates mediators such as banks from the payment processing system. It reduces the processing time and accelerates the transaction speed, consequently adding to the increasing popularity of such platforms. In addition, the growing prevalence of cryptocurrencies as an investment option among millennials is also fueling the growth of the cryptocurrency payment apps industry.” It continued: “One of the most transformative trends in the market is the increasing interoperability between crypto payment platforms and traditional banking systems. Crypto apps now allow users to seamlessly convert digital assets into fiat currencies and vice versa, enabling easier withdrawals, direct-to-bank transfers, and debit card functionalities. This fusion is bridging the gap between old and new financial infrastructures, encouraging a smoother transition for users hesitant to move entirely into decentralized finance (DeFi). Thus, increasing integration of cryptocurrency payment apps with traditional financial systems can be attributed to the market’s growth.” Active companies in the markets this week include Amaze Holdings, Inc. (NYSE American: AMZE), Shopify Inc. (NASDAQ: SHOP), Roblox Corporation (NYSE: RBLX), PayPal Holdings, Inc. (NASDAQ: PYPL), Hut 8 Corp. (NASDAQ: HUT).

BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase common stock in an underwritten public offering. Gain expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock and/or the warrants offered in the offering. All of the securities are being offered by the Company.